These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 19201471)

  • 41. Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline.
    Grung M; Källqvist T; Sakshaug S; Skurtveit S; Thomas KV
    Ecotoxicol Environ Saf; 2008 Oct; 71(2):328-40. PubMed ID: 18068226
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The treatment of hospital wastewater: an appraisal.
    Pauwels B; Verstraete W
    J Water Health; 2006 Dec; 4(4):405-16. PubMed ID: 17176811
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Removal and environmental exposure of alcohol ethoxylates in US sewage treatment.
    Morrall SW; Dunphy JC; Cano ML; Evans A; McAvoy DC; Price BP; Eckhoff WS
    Ecotoxicol Environ Saf; 2006 May; 64(1):3-13. PubMed ID: 16140378
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of the pharmaceuticals for human use contaminating the Italian aquatic environment.
    Zuccato E; Castiglioni S; Fanelli R
    J Hazard Mater; 2005 Jul; 122(3):205-9. PubMed ID: 15967275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human pharmaceuticals in US surface waters: a human health risk assessment.
    Schwab BW; Hayes EP; Fiori JM; Mastrocco FJ; Roden NM; Cragin D; Meyerhoff RD; D'Aco VJ; Anderson PD
    Regul Toxicol Pharmacol; 2005 Aug; 42(3):296-312. PubMed ID: 15979221
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Occurrence of anionic surfactants in treated sewage: risk assessment to aquatic environment.
    Mungray AK; Kumar P
    J Hazard Mater; 2008 Dec; 160(2-3):362-70. PubMed ID: 18430511
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effluent from drug manufactures contains extremely high levels of pharmaceuticals.
    Larsson DG; de Pedro C; Paxeus N
    J Hazard Mater; 2007 Sep; 148(3):751-5. PubMed ID: 17706342
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Illicit drugs and pharmaceuticals in the environment--forensic applications of environmental data, Part 2: Pharmaceuticals as chemical markers of faecal water contamination.
    Kasprzyk-Hordern B; Dinsdale RM; Guwy AJ
    Environ Pollut; 2009 Jun; 157(6):1778-86. PubMed ID: 19299056
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of extraction method of pharmaceuticals and their occurrences found in Japanese wastewater treatment plants.
    Okuda T; Yamashita N; Tanaka H; Matsukawa H; Tanabe K
    Environ Int; 2009 Jul; 35(5):815-20. PubMed ID: 19201472
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A broad spectrum analytical scheme for the screening of endocrine disruptors (EDs), pharmaceuticals and personal care products in wastewaters and natural waters.
    Bruchet A; Prompsy C; Fillppi G; Souall A
    Water Sci Technol; 2002; 46(3):97-104. PubMed ID: 12227610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification and evaluation of computer models for predicting environmental concentrations of pharmaceuticals and veterinary products in the Nordic environment.
    Wajsman D; Rudén C
    J Expo Sci Environ Epidemiol; 2006 Jan; 16(1):85-97. PubMed ID: 16030525
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prioritization and analysis of pharmaceuticals for human use contaminating the aquatic ecosystem in Italy.
    Riva F; Zuccato E; Castiglioni S
    J Pharm Biomed Anal; 2015 Mar; 106():71-8. PubMed ID: 25459268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of Carbamazepine in wastewater treatment and during groundwater infiltration.
    Clara M; Strenn B; Kreuzinger N
    Water Res; 2004 Feb; 38(4):947-54. PubMed ID: 14769414
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Occurrence and removal of N-nitrosamines in wastewater treatment plants.
    Krauss M; Longrée P; Dorusch F; Ort C; Hollender J
    Water Res; 2009 Sep; 43(17):4381-91. PubMed ID: 19608213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water.
    Mompelat S; Le Bot B; Thomas O
    Environ Int; 2009 Jul; 35(5):803-14. PubMed ID: 19101037
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Consumption and occurrence of pharmaceutical and personal care products in the aquatic environment in Spain.
    Ortiz de García S; Pinto Pinto G; García Encina P; Irusta Mata R
    Sci Total Environ; 2013 Feb; 444():451-65. PubMed ID: 23287535
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preliminary ecological risk assessment of butylparaben and benzylparaben -1. Removal efficiency in wastewater treatment, acute/chronic toxicity for aquatic organisms, and effects on medaka gene expression.
    Yamamoto H; Watanabe M; Hirata Y; Nakamura Y; Nakamura Y; Kitani C; Sekizawa J; Uchida M; Nakamura H; Kagami Y; Koshio M; Hirai N; Tatarazako N
    Environ Sci; 2007; 14 Suppl():73-87. PubMed ID: 18382416
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effluent-dominated streams. Part 2: Presence and possible effects of pharmaceuticals and personal care products in Wascana Creek, Saskatchewan, Canada.
    Waiser MJ; Humphries D; Tumber V; Holm J
    Environ Toxicol Chem; 2011 Feb; 30(2):508-19. PubMed ID: 21072845
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Determining the fraction of pharmaceutical residues in wastewater originating from a hospital.
    Ort C; Lawrence MG; Reungoat J; Eaglesham G; Carter S; Keller J
    Water Res; 2010 Jan; 44(2):605-15. PubMed ID: 19717180
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Newly Designed Water Treatment Systems for Hospital Effluent].
    Azuma T
    Yakugaku Zasshi; 2018; 138(3):289-296. PubMed ID: 29503418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.